FDA commissioner appointment delayed past July 2026
user-generated· regulatory
FDA commissioner appointment delayed past July 2026
Market overview
The Trump administration will fail to fill the FDA commissioner role before the July 2026 deadline due to political infighting or opposition. This delay will trigger industry concerns over drug approval slowdowns and regulatory uncertainty.
regulatory prediction market
- Implied probability (Yes)
- 80%
Source: user-generated
More regulatory markets
- House passes ban on midcycle redistricting by Dec 2026 — 60% Yes
- Ban Flock Act fails to pass Senate committee — 75% Yes
- AI pause proposal fails to pass Congress by 2028 — 75% Yes
- US issues executive order on AI agent autonomy — 50% Yes
- US state adopts slavery reparations program by 2028 — 60% Yes
- NTSB releases preliminary crash report by year-end — 85% Yes
- Australian government approves acquisition by 2027 — 70% Yes
- North Dakota to allocate $50M for bison conservation by 2027 — 70% Yes
No one's made a Conviction call on this yet. Be the first to call it →
Loading…